Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

Philip J. Mease*, Dafna D. Gladman, Christopher T. Ritchlin, Eric M Ruderman, Serge D. Steinfeld, Ernest H.S. Choy, John T. Sharp, Peter A. Ory, Renee J. Perdok, Mark A. Weinberg

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

774 Scopus citations

Fingerprint

Dive into the research topics of 'Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences